The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT)

Background: The AML EBMT Cytogenetic Risk score is a new prognostic model recently published (Canaani et al. Leukemia. 2019 Aug;33(8):1944-1952; Nagler el al. Am J Hematol. 2020 Jun 12) combining cytogenetics and FLT3ITD status for AML patients in complete remission (CR) at transplant time. The AML...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2020-11, Vol.136 (Supplement 1), p.19-20
Hauptverfasser:	Beauverd, Yan, Morin, Sarah, Nabergoj, Mitja, Stephan, Caroline, De Ramon Ortiz, Carmen, Mamez, Anne-Claire, Mahne, Elif, Petropoulou, Anna, Giannotti, Federica, Simonetta, Federico, Ayer, Christian, Bruno, Benjamin, Bounaix, Laura, Anastasiou, Maria, Mappoura, Maria, Tran, Thien-An, Masouridi-Levrat, Stavroula, Chalandon, Yves
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!